🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Compare the activity of 5 mg levocetirizine and 5 mg desloratadine on aller...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00521170
Treatments Being Tested
The study is a Phase II, dose-ranging, multicenter, randomized, double-blin...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00866788
Treatments Being Tested
Allen Kaplan is a prominent American allergist with the reputation of leade...
Status
Completed
Location
Medical University Sofia, Department of Allergology
Start Date
2011-03
Trial ID
NCT01250652
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics and safety of...
Status
Completed
Location
Samsung medical center
Start Date
2012-07
Trial ID
NCT01651481
Treatments Being Tested
This is a single center, single blind, single dose, randomized, partial cro...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-03-18
Trial ID
NCT02447393
Treatments Being Tested
This is a single-dose, Randomized, two-period,cross over pivotal study. The...
Status
Completed
Location
Accutest Research Lab (I) Pvt. Ltd.
Start Date
2012-02
Trial ID
NCT01567501
Treatments Being Tested
This study is a randomized, open label, single dose, two-way crossover clin...
Status
Completed
Location
Chonbuk National University Hospital
Start Date
2017-07-19
Trial ID
NCT03371849
Treatments Being Tested
Antihistamines are commonly used and currently levocetirizine is most frequ...
Status
Completed
Location
Royal Netherlands Navy
Start Date
2012-04
Trial ID
NCT01496911
Treatments Being Tested
The purpose of this study is to compare two different formulations (test \&...
Status
Completed
Location
Covance Dallas
Start Date
2022-10-05
Trial ID
NCT05565729
Treatments Being Tested
Phase IV, human pharmacology, exploratory, randomized, 3-way (3 treatment p...
Status
Completed
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT00150761
Treatments Being Tested